Mayo Clinic proceedings · 2026
Self-Reported Health, Stress, and Lifestyle Behaviors Among U.S. Chief Executive Officers: A Comparison of Two Cohorts.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Croghan Ivana T, Casey Michael A, Pagel Erin M, Fischer Karen M, Nolen Melanie, Dougan Brian M, Schroeder Darrell R, Fokken Shawn C, Gilman Elizabeth A, Ressler Steven W, Bonnes Sara L, Shufelt Chrisandra L, Dudenkov Daniel V, Hayden Michael, Emperor Michael, Thilagar Bright P, VerNess Christina D, Anderson Stephanie L, Ghosh Karthik, Hurt Ryan T
Аннотация
OBJECTIVE: To evaluate self-reported health and lifestyle behaviors among U.S. Chief Executive Officers (CEOs) and to identify patterns relevant to executive healthcare delivery.
PATIENTS AND METHODS: An anonymous health and lifestyle survey was distributed to two populations: patients enrolled in the Mayo Clinic Executive Health Program (MC-EHP; n=14,240) and members of the Chief Executive Group (CEG; n=146,641). Data were collected between August 8 and October 2, 2025. Descriptive statistics were summarized for CEO survey responders (MC-EHP, n=792; CEG, n=613). Group comparisons were performed using Kruskal-Wallis and chi-square tests. No adjustment was made for multiple comparisons; therefore, inferential findings should be interpreted as exploratory.
RESULTS: Compared with CEG CEOs, MC-EHP CEOs were older (P<.001), more likely to be male (83.5% vs 76.1%; P<.001) and White (97.0% vs 93.0%; P=.001). MC-EHP CEOs self-reported less sedentary time (6.1 vs. 6.8 hours/day; P<.001), fewer work hours (40.3 hours vs 53.8 hours/week; P<.001), and lower stress levels (4.6 vs. 6.3, P<.001). They also reported fewer sleep disturbances (P=.003), fewer chronic medical conditions and higher quality-of-life (P<.001). Use of prescription medications was higher among the MC-EHP CEOs (78.6% vs 72.0%, P=.004), whereas use of over-the-counter medications/supplements was lower (P=.022). Several statistically significant differences were modest in absolute magnitude.
CONCLUSION: Among surveyed U.S. CEOs, participation in a comprehensive executive health program was associated with lower self-reported stress, healthier lifestyle behaviors, and higher quality-of-life. The findings underscore lifestyle factors relevant to overall health and highlight areas for clinicians to prioritize when treating CEO patients. Prior research suggests that CEO well-being may have broader implications for employee well-being, further supporting the need for regular patient feedback to help executive health programs adapt healthcare services to the evolving needs of their patients.
PATIENTS AND METHODS: An anonymous health and lifestyle survey was distributed to two populations: patients enrolled in the Mayo Clinic Executive Health Program (MC-EHP; n=14,240) and members of the Chief Executive Group (CEG; n=146,641). Data were collected between August 8 and October 2, 2025. Descriptive statistics were summarized for CEO survey responders (MC-EHP, n=792; CEG, n=613). Group comparisons were performed using Kruskal-Wallis and chi-square tests. No adjustment was made for multiple comparisons; therefore, inferential findings should be interpreted as exploratory.
RESULTS: Compared with CEG CEOs, MC-EHP CEOs were older (P<.001), more likely to be male (83.5% vs 76.1%; P<.001) and White (97.0% vs 93.0%; P=.001). MC-EHP CEOs self-reported less sedentary time (6.1 vs. 6.8 hours/day; P<.001), fewer work hours (40.3 hours vs 53.8 hours/week; P<.001), and lower stress levels (4.6 vs. 6.3, P<.001). They also reported fewer sleep disturbances (P=.003), fewer chronic medical conditions and higher quality-of-life (P<.001). Use of prescription medications was higher among the MC-EHP CEOs (78.6% vs 72.0%, P=.004), whereas use of over-the-counter medications/supplements was lower (P=.022). Several statistically significant differences were modest in absolute magnitude.
CONCLUSION: Among surveyed U.S. CEOs, participation in a comprehensive executive health program was associated with lower self-reported stress, healthier lifestyle behaviors, and higher quality-of-life. The findings underscore lifestyle factors relevant to overall health and highlight areas for clinicians to prioritize when treating CEO patients. Prior research suggests that CEO well-being may have broader implications for employee well-being, further supporting the need for regular patient feedback to help executive health programs adapt healthcare services to the evolving needs of their patients.